Lindner Center’s Dr. McElroy Investigates Experimental Drug to Treat Depression

Lindner Center of HOPE’s Chief Research Officer, Dr. Susan McElroy, was recently cited in a Forbes article about her work in the investigation of an experimental drug that could be used in the treatment of depression.

Naurex, a private company founded by a Northwestern University professor in Evanston, Ill., is reporting that this experimental drug works to help push patients out of a major depressive state within 24 hours of getting a single intravenous shot.

Click here to read the Forbes article.

This entry was posted in Blog, Depression, Lindner Center of HOPE, Lindner Center of HOPE News, Mood Disorder, News, Press Releases, Research, Staff Announcements. Bookmark the permalink.